$PRPO
Precipio, Inc. Stock $prpo

$prpo Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000104396115000018 Filed on November 16, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q4
Revenue	$410.0K	$330.0K	$7.696M
YoY Change	-94.67%	-91.88%	23.77%
Cost Of Revenue	$570.0K	$445.0K	-$4.720M
YoY Change	-112.08%	-81.04%	-214.01%
Gross Profit	-$160.0K	-$115.0K	$2.619M
YoY Change	-106.11%	-106.7%	26.16%
Gross Profit Margin	-39.02%	-34.85%	34.03%
Selling, General & Admin	$1.660M	$1.686M	-$7.470M
YoY Change	-122.22%	-66.7%	-256.28%
% of Gross Profit			-285.22%
Research & Development	$480.0K	$455.0K	$80.00K
YoY Change	500.0%	-29.02%	-91.21%
% of Gross Profit			3.05%
Depreciation & Amortization	$150.0K	$100.0K	-$1.000M
YoY Change	-115.0%	-83.02%	-253.85%
% of Gross Profit			-38.18%
Operating Expenses	$2.140M	$2.141M	-$7.390M
YoY Change	-128.96%	-62.46%	-229.88%
Operating Profit	-$2.300M	-$2.256M	$10.01M
YoY Change	-122.98%	-43.42%	-376.95%
Interest Expense	-$350.0K	$210.0K	$80.00K
YoY Change	-537.5%	-200.0%	-116.67%
% of Operating Profit			0.8%
Other Income/Expense, Net	$20.00K	-$6.000K	$0.00
YoY Change		500.0%	-100.0%
Pretax Income	-$2.640M	-$2.051M	$1.830M
YoY Change	-244.26%	-51.17%	-144.74%
Income Tax	$0.00	$0.00	$1.200M
% Of Pretax Income			65.57%
Net Earnings	-$19.34M	-$7.299M	-$5.793M
YoY Change	233.85%	9023.75%	45.48%
Net Earnings / Revenue	-4717.07%	-2211.82%	-75.27%
Basic Earnings Per Share
Diluted Earnings Per Share	-$644.7M	-$243.3M	-$289.5M
COMMON SHARES
Basic Shares Outstanding	13.92M shares	13.87M shares	8.084M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$440.0K	$2.790M	$1.610M
YoY Change	-72.67%	217.05%	-1.23%
Cash & Equivalents	$235.0K	$2.787M	$1.609M
Short-Term Investments
Other Short-Term Assets	$537.0K	$534.0K	$385.0K
YoY Change	39.48%	-68.84%	-58.96%
Inventory	$50.00K		$0.00
Prepaid Expenses	$200.0K
Receivables	$264.0K	$9.252M	$466.0K
Other Receivables	$200.0K	$0.00	$0.00
Total Short-Term Assets	$3.282M	$16.10M	$28.57M
YoY Change	-88.51%	17.63%	141.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$259.0K	$303.0K	$485.0K
YoY Change	-46.6%	-81.66%	-75.79%
Goodwill	$0.00	$6.918M	$6.918M
YoY Change	-100.0%	0.0%	0.0%
Intangibles	$1.170M	$1.000M	$751.0K
YoY Change	55.79%	-87.97%	-91.83%
Long-Term Investments
YoY Change
Other Assets	$105.0K	$125.0K	$204.0K
YoY Change	-48.53%	-54.71%	-37.61%
Total Long-Term Assets	$1.534M	$8.346M	$1.440M
YoY Change	6.53%	-51.36%	-92.19%
TOTAL ASSETS
Total Short-Term Assets	$3.282M	$16.10M	$28.57M
Total Long-Term Assets	$1.534M	$8.346M	$1.440M
Total Assets	$4.816M	$24.45M	$30.01M
YoY Change	-83.95%	-20.74%	-0.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.781M	$3.732M	$3.898M
YoY Change	-3.0%	10.45%	36.29%
Accrued Expenses	$3.734M	$2.368M	$2.045M
YoY Change	82.59%	20.82%	0.39%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$7.596M	$6.275M	$462.0K
YoY Change	1544.16%	353.72%	90.91%
Total Short-Term Liabilities	$16.98M	$16.15M	$11.99M
YoY Change	41.67%	64.6%	38.97%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$525.0K	$7.375M
YoY Change	-100.0%	-90.64%	16.73%
Other Long-Term Liabilities	$305.0K	$886.0K	$817.0K
YoY Change	-62.67%	-55.0%	-37.3%
Total Long-Term Liabilities	$305.0K	$1.411M	$8.192M
YoY Change	-96.28%	-81.39%	7.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.98M	$16.15M	$11.99M
Total Long-Term Liabilities	$305.0K	$1.411M	$8.192M
Total Liabilities	$17.64M	$17.73M	$23.45M
YoY Change	-24.8%	-13.98%	24.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$213.4M	-$194.1M	-$183.6M
YoY Change	16.25%	9.34%	8.95%
Common Stock	$139.0K	$139.0K	$81.00K
YoY Change	71.6%	90.41%	10.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$12.82M	$6.717M	$6.553M
YoY Change
Total Liabilities & Shareholders Equity	$4.816M	$24.45M	$30.01M
YoY Change	-83.95%	-20.74%	-0.9%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q4
OPERATING ACTIVITIES
Net Income	-$19.34M	-$7.299M	-$5.793M
YoY Change	233.85%	9023.75%	45.48%
Depreciation, Depletion And Amortization	$150.0K	$100.0K	-$1.000M
YoY Change	-115.0%	-83.02%	-253.85%
Cash From Operating Activities	-$2.940M	-$3.430M	-$2.490M
YoY Change	18.07%	-13.16%	16.36%
INVESTING ACTIVITIES
Capital Expenditures	$80.00K	-$90.00K	-$10.00K
YoY Change	-900.0%	800.0%	-88.89%
Acquisitions
YoY Change
Other Investing Activities	$90.00K	$1.950M	$170.0K
YoY Change	-47.06%	-46.58%	-342.86%
Cash From Investing Activities	$170.0K	$1.860M	$160.0K
YoY Change	6.25%	-48.9%	-194.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	2.040M	3.080M
YoY Change	-100.0%	20300.0%	-3950.0%
NET CHANGE
Cash From Operating Activities	-2.940M	-3.430M	-2.490M
Cash From Investing Activities	170.0K	1.860M	160.0K
Cash From Financing Activities	0.000	2.040M	3.080M
Net Change In Cash	-2.770M	470.0K	750.0K
YoY Change	-469.33%	-256.67%	-131.38%
FREE CASH FLOW
Cash From Operating Activities	-$2.940M	-$3.430M	-$2.490M
Capital Expenditures	$80.00K	-$90.00K	-$10.00K
Free Cash Flow	-$3.020M	-$3.340M	-$2.480M
YoY Change	21.77%	-15.23%	20.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	9000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001043961
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13915691	shares
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	TRANSGENOMIC INC
	tbio	Accounts Receivable General Payment Terms1 AccountsReceivableGeneralPaymentTerms1	P30D
	tbio	Accounts Receivable International Extended Payment Terms Greaterthan1 AccountsReceivableInternationalExtendedPaymentTermsGreaterthan1	P90D
	tbio	Class Of Warrant Or Right Number Of Issued Warrants Or Rights ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights	115432	shares
	tbio	Class Of Warrant Or Right Number Of Issued Warrants Or Rights ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights	3466841	shares
CY2014Q4	tbio	Dividends Preferred Stock Cash Not Declared DividendsPreferredStockCashNotDeclared	3100000	USD
CY2015Q3	tbio	Dividends Preferred Stock Cash Not Declared DividendsPreferredStockCashNotDeclared	4100000	USD
	tbio	Dividends Preferred Stock Cash Reversal DividendsPreferredStockCashReversal	3130000	USD
CY2015Q3	tbio	Effective Tax Rate Reconciliation Permanent Differences Goodwill Amortization EffectiveTaxRateReconciliationPermanentDifferencesGoodwillAmortization	100000	USD
	tbio	Effective Tax Rate Reconciliation Permanent Differences Goodwill Amortization EffectiveTaxRateReconciliationPermanentDifferencesGoodwillAmortization	100000	USD
	tbio	Fair Value Assumptions Percentage Of Simulated Equity Values Below Down Round Financing Cut Off Point FairValueAssumptionsPercentageOfSimulatedEquityValuesBelowDownRoundFinancingCutOffPoint	0.25
CY2015Q3	tbio	Finite Lived Intangible Assets Accumulated Impairment FiniteLivedIntangibleAssetsAccumulatedImpairment	6165000	USD
CY2015Q3	tbio	Finite Lived Intangible Assets Amortization Expense Current Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseCurrentFiscalYear	1200000	USD
CY2014Q4	tbio	Furniture Fixtures And Leasehold Improvements Gross FurnitureFixturesAndLeaseholdImprovementsGross	1855000	USD
CY2015Q3	tbio	Furniture Fixtures And Leasehold Improvements Gross FurnitureFixturesAndLeaseholdImprovementsGross	1566000	USD
CY2014Q3	tbio	Gain Loss On Stock Warrants Revaluation GainLossOnStockWarrantsRevaluation	-50000	USD
	tbio	Gain Loss On Stock Warrants Revaluation GainLossOnStockWarrantsRevaluation	200000	USD
CY2015Q3	tbio	Gain Loss On Stock Warrants Revaluation GainLossOnStockWarrantsRevaluation	385000	USD
	tbio	Gain Loss On Stock Warrants Revaluation GainLossOnStockWarrantsRevaluation	-30000	USD
CY2014Q3	tbio	Interest Income And Expense Net InterestIncomeAndExpenseNet	-162000	USD
	tbio	Interest Income And Expense Net InterestIncomeAndExpenseNet	-490000	USD
CY2015Q3	tbio	Interest Income And Expense Net InterestIncomeAndExpenseNet	-174000	USD
	tbio	Interest Income And Expense Net InterestIncomeAndExpenseNet	-550000	USD
	tbio	Other Income Expense OtherIncomeExpense	-599000	USD
	tbio	Issuance Of Warrants Expected Exercise Period IssuanceOfWarrantsExpectedExercisePeriod	P1Y4M8D
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1178000	USD
CY2014Q3	tbio	Other Income Expense OtherIncomeExpense	-213000	USD
	tbio	Other Income Expense OtherIncomeExpense	-291000	USD
CY2015Q3	tbio	Other Income Expense OtherIncomeExpense	205000	USD
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	3650000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1609000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2787000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-746000	USD
CY2014Q3	tbio	Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision	1158000	USD
	tbio	Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision	2681000	USD
CY2015Q3	tbio	Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision	1057000	USD
	tbio	Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision	3787000	USD
CY2015Q3	tbio	Working Capital Deficiency WorkingCapitalDeficiency	-43000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3898000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3732000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5389000	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9252000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2295000	USD
CY2015Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2368000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8087000	USD
CY2015Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6859000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	340000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	326000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	189680000	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	200285000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	527000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3497000	USD
CY2014Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3700000	USD
CY2014Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4458000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	7679000	USD
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	8158000	USD
CY2015Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	9040000	USD
CY2014Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	400000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1720000	USD
CY2015Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	175000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2426000	USD
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	400000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000000	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	400000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1100000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5524030	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10392728	shares
CY2014Q4	us-gaap	Assets Assets	30006000	USD
CY2015Q3	us-gaap	Assets Assets	24450000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	13647000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	16104000	USD
CY2014Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	5599000	USD
CY2015Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	3531000	USD
CY2014Q3	us-gaap	Capital Leases Income Statement Amortization Expense CapitalLeasesIncomeStatementAmortizationExpense	100000	USD
	us-gaap	Capital Leases Income Statement Amortization Expense CapitalLeasesIncomeStatementAmortizationExpense	200000	USD
CY2015Q3	us-gaap	Capital Leases Income Statement Amortization Expense CapitalLeasesIncomeStatementAmortizationExpense	100000	USD
	us-gaap	Capital Leases Income Statement Amortization Expense CapitalLeasesIncomeStatementAmortizationExpense	200000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1626000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	880000	USD
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	1910000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-277000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	229000	USD
CY2014Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.25
CY2015Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.56
CY2014Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.73
CY2014Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.86
CY2015Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.56
CY2015Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	9.59
CY2015Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.50
CY2014Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1387685	shares
CY2015Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1881396	shares
CY2014Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1212665	shares
CY2014Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1309785	shares
CY2015Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1881396	shares
CY2015Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1483161	shares
CY2015Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2188177	shares
CY2015Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6351826	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8084471	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13915691	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8084471	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13915691	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	81000	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	139000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-125000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8160000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7321000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13629000	USD
CY2014Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2347000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6891000	USD
CY2015Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2196000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6732000	USD
CY2014Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	7837000	USD
CY2015Q3	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	6800000	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1012000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	298000	USD
CY2015Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	137000	USD
CY2014Q3	us-gaap	Depreciation Depreciation	100000	USD
	us-gaap	Depreciation Depreciation	300000	USD
CY2015Q3	us-gaap	Depreciation Depreciation	100000	USD
	us-gaap	Depreciation Depreciation	300000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1493000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1527000	USD
CY2014Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3130000	USD
CY2015Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.22
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.55
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.24
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	2000	USD
CY2015Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0557
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0318
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	682000	USD
CY2015Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	566000	USD
CY2015Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	600000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-200000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	30000	USD
	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P1Y6M
	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	1.04
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0045
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5672000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6854000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	100000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	100000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	100000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	100000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	13551000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14019000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7879000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1000000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-14000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	6918000	USD
CY2015Q3	us-gaap	Goodwill Goodwill	6918000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	1717000	USD
	us-gaap	Gross Profit GrossProfit	4704000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	1764000	USD
	us-gaap	Gross Profit GrossProfit	6938000	USD
CY2015Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	6100000	USD
CY2014Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2015Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	7024000	USD
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	7024000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2744000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11409000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8233000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-14193000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4200000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12613000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8719000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14659000	USD
CY2014Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	2664000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	3260000	USD
CY2015Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	934000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	578000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1456000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1204000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-486000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-466000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	547000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-162000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5524000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6613000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-590000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-122000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	236000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	61000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-31000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-911000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	312000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-224000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7879000	USD
CY2015Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1000000	USD
	us-gaap	Interest Paid InterestPaid	181000	USD
	us-gaap	Interest Paid InterestPaid	365000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	23453000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	17733000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30006000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24450000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11257000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	16147000	USD
CY2014Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2554000	USD
CY2015Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2002000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	462000	USD
CY2015Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	6275000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7375000	USD
CY2015Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	525000	USD
CY2014Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	7590000	USD
CY2015Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	5596000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6991000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8983000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3473000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1621000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-177000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-289000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11209000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9428000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-10932000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-9657000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-80000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8149000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-7299000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-13615000	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-384000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8988000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7630000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14608000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2015Q3	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	5704000	USD
	us-gaap	Operating Expenses OperatingExpenses	17026000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	10688000	USD
	us-gaap	Operating Expenses OperatingExpenses	20998000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3987000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12322000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8924000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14060000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	200000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	500000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	800000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	800000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	600000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	200000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	500000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	400000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1050000	USD
CY2015Q3	us-gaap	Other Assets Current OtherAssetsCurrent	534000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	204000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	125000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-45000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-11000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-22000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-14000	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1068000	USD
CY2015Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1067000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1546000	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	886000	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	56000	USD
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	121000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	280000	USD
CY2014Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	304000	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	839000	USD
CY2015Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	331000	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	993000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4029502	shares
CY2015Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4029502	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4029502	shares
CY2015Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4029502	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	40000	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	40000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8969000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	6906000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2015Q3	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	3000000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	6440000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	923000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9445000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7162000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1358000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	303000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2681000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2731000	USD
CY2015Q3	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	500000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	113000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	35000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	6242000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	874000	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	641000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2171000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	561000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1704000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-183588000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-194073000	USD
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	4064000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	11595000	USD
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	3960000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	13670000	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5063000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14855000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3103000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	88361	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	39469	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	237546	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	33550	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	641560	shares
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12270000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	997000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	489000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P1Y4M10D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.84
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0191
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	325111	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.68
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	685984	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1199714	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.56
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.62
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	981938	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	10.60
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.88
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.51
CY2015Q3	us-gaap	Share Price SharePrice	0.92
CY2015Q3	us-gaap	Share Price SharePrice	1.42
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y0M0D
CY2015Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1500000	shares
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1167000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8969000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	6553000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	6717000	USD
CY2015Q3	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	900000	USD
CY2014Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	145000	USD
CY2015Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	175000	USD
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7353695	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7353695	shares
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13763240	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	11784583	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior year amounts have been reclassified to conform to the current year presentation in our condensed consolidated financial statements, which consists of the effects of reclassifications from the presentation of our discontinued operations.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. In addition, estimates and assumptions associated with the determination of the fair value of certain assets and related impairments require considerable judgment by management. Actual results could differ from the estimates and assumptions used in preparing these condensed consolidated financial statements.</font></div></div>

Files In Submission

Name	View Source	Status
0001043961-15-000018-index-headers.html	Edgar Link	pending
0001043961-15-000018-index.html	Edgar Link	pending
0001043961-15-000018.txt	Edgar Link	pending
0001043961-15-000018-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tbio-20150930.xml	Edgar Link	completed
tbio-20150930.xsd	Edgar Link	pending
tbio-20150930x10q.htm	Edgar Link	pending
tbio-20150930_cal.xml	Edgar Link	unprocessable
tbio-20150930_def.xml	Edgar Link	unprocessable
tbio-20150930_lab.xml	Edgar Link	unprocessable
tbio-20150930_pre.xml	Edgar Link	unprocessable
tbio-ex101_20150930x10q.htm	Edgar Link	pending
tbio-ex102_20150930x10q.htm	Edgar Link	pending
tbio-ex103_20150930x10q.htm	Edgar Link	pending
tbio-ex311_20150930x10q.htm	Edgar Link	pending
tbio-ex321_20150930x10q.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRPO
Precipio, Inc. Stock $prpo

2015 Q4 Form 10-Q Financial Statement

#000104396115000018 Filed on November 16, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRPO Precipio, Inc. Stock $prpo

2015 Q4 Form 10-Q Financial Statement

#000104396115000018 Filed on November 16, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRPO
Precipio, Inc. Stock $prpo